ahlam1399
03-12-2016, 05:09 AM
UPDATE 1-Infection worries prompt regulatory reviews of Gilead leukaemia drug
LONDON, March 11 (Reuters) - European and U.S. regulatorsare reviewing the safety of Gilead Sciences' leukaemiadrug Zydelig due to concerns over serious adverse events,including deaths.http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=bx6DJZs6I6Q:2t3ebHbhNFg:yI l2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=bx6DJZs6I6Q:2t3ebHbhNFg:V_ sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=bx6DJZs6I6Q:2t3ebHbhNFg:V_ sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=bx6DJZs6I6Q:2t3ebHbhNFg:F7 zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=bx6DJZs6I6Q:2t3ebHbhNFg:F7 zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/governmentfilingsNews/~4/bx6DJZs6I6Q
LONDON, March 11 (Reuters) - European and U.S. regulatorsare reviewing the safety of Gilead Sciences' leukaemiadrug Zydelig due to concerns over serious adverse events,including deaths.http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=bx6DJZs6I6Q:2t3ebHbhNFg:yI l2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=bx6DJZs6I6Q:2t3ebHbhNFg:V_ sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=bx6DJZs6I6Q:2t3ebHbhNFg:V_ sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=bx6DJZs6I6Q:2t3ebHbhNFg:F7 zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=bx6DJZs6I6Q:2t3ebHbhNFg:F7 zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/governmentfilingsNews/~4/bx6DJZs6I6Q